Clinical development strategy and study design 

• Contribute to the clinical development plan for the assigned asset, including dose-escalation strategy, cohort design and endpoint selection. 

• Author clinical study protocols, amendments and informed consent forms, and coordinate cross-functional review to approval. 

• Translate preclinical, dosimetry and emerging clinical data into study design. 

Program and project management 

• Serve as the day-to-day clinical lead and primary point of contact for the assigned asset across all functions. 

• Chair or co-chair study team meetings: set the agenda, drive decisions to closure, and track actions to completion. 

• Manage study budget and forecast in partnership with Clinical Operations and Finance. 

Data, safety and decision-making 

• Own ongoing clinical data review and scientific data cleaning in partnership with the Medical Monitor and data management.  

• Prepare and run Safety Review Committee and dose-escalation meetings, including data packages, dose recommendations, minutes and follow-through. 

• Support safety surveillance, SAE reconciliation and signal evaluation. 

• Contribute to statistical analysis plans and review of outputs. 

• Prepare clinical data and interpretation for internal governance, investor and partner interactions. 

Regulatory and documentation 

• Contribute clinical content to IND/CTA submissions, Investigator's Brochures, DSURs, briefing books and responses to health authority questions. 

• Contribute to clinical study reports and ensure the clinical narrative is supported by the data. 

Sites, vendors and external engagement 

• Support site feasibility, selection and activation. 

• Deliver protocol training at site initiation visits and investigator meetings and act as the clinical point of escalation for protocol questions. 

• Build relationships with investigators, steering committee members and advisory boards. 

• Contribute to abstracts, posters, manuscripts and congress presentations.

• Advanced degree (MSc, PhD, PharmD, MD or equivalent) in life sciences, pharmacy, medicine or a closely related discipline. 

• Minimum 4 years of clinical development experience for appointment. Experience may be gained in industry or at a CRO and must include hands-on responsibility for at least one oncology study. 

• Demonstrated protocol authoring, including at least one protocol taken from concept through to approval. 

• Hands-on experience of clinical data review, query resolution, and preparation of data packages for safety or dose-escalation committees. 

• Experience with early-phase oncology trial design, including dose escalation, DLT definition and cohort expansion. 

• Ability to read and interrogate imaging, dosimetry, pharmacokinetic and biomarker data. 

• Direct experience with radiopharmaceutical oncologic therapies.  

• Experience with prostate cancer therapies and landscape.  

• Experience of studies conducted in both the US, Australia and Europe. 

• Comfortable working in a fast-paced biotech environment, hands on and self-directed 

• Team player who thrives on collaboration and cross-functional flexibility. 

• Detail-oriented without losing sight of the program as a whole. 

• Commitment to safety, quality, continuous improvement and staying current with industry trends and advances. 

• A unique chance to contribute to first-in-class cancer therapies. 

• Exposure to both imaging and clinical development in a dynamic biotech setting. 

• Hands-on training and professional development opportunities. 

• An international, collaborative, and supportive work culture. 

• Competitive compensation and benefits.